Page 377 - Binder2
P. 377
2. Clinical reorientation.
For forward-thinking clinics, this shift creates opportunity.
They can:
• Focus on outcomes over volume.
• Deploy staff in remote support roles, not just
procedural ones.
• Leverage AI-enabled platforms to track long-term
therapeutic efficacy with less overhead.
Rather than scaling up complexity, clinics that embrace
plant-based platforms can scale down—and scale out—as
accessible, digitally connected, biologics-literate
community hubs.
3. Pharmacies: From Centralized Dispensers to
Decentralized Networks
Specialty pharmacies emerged to meet the demands of
complex biologic logistics:
• Refrigeration from manufacturing to patient.
• Complex insurance coordination.
• Monitoring refill compliance for high-cost drugs.
• Managing narrow dispensing windows.
In return, they’ve become a multibillion-dollar segment of
the pharmaceutical supply chain—often extracting value
simply for navigating complexity.
But what happens when the complexity disappears?
With edible biologics:
375

